Biomedical Evaluation of Nanomedicines

摘要：

At present, scientists must accept that it is still very early in the toxicological evaluation for nanomaterials and nanomedicines, and few data on the safety and toxicity. The safety evaluation of nanomedicines includes workforce exposure limits in manufacturing process, environment impact with general impact and to patients after administration and safety for human use, such as depends on route of administration, dose and dosing frequency, as well as safety in drug delivery relates to toxicity of drug payload. The biomedical evaluation of nanomedicines includes biodistribution, metabolic fate, Persistance of non-degradable systems, Specific therapeutic issues and immunogenicity. We attend on the relative issues of nanomedicines with human health and safety and toxicity to develop the evaluation methods of nanoproducts and make nanotechnology play a great role in the progress in nanotechnology and medicines and medicine engineering.

作者: Chang-Xiao Liu

作者单位: Tianjin State Key Laboratory of Pharmacokinetics and Pharmacodynamics, Tianjin Institute of Pharmaceutical Research, Tianjin 300193

会议类型: 国际会议

会议名称: International Symposium on Crystal Engineering and Drug Delivery System 2009(2009晶体工程与药物传送系统国际会议)

会议地点: 天津

会议语种:英文

页码: 320-324

在线出版日期: 2009-09-05（万方平台首次上网日期，不代表论文的发表时间）